Kazuhiro Ooe

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsAcceleratorsGene and molecular therapyPredictive and prognostic markersAutomotive combustion and fuel engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 19, 2025
An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma.

Hiroyuki Suzuki, Saki Yamashita, Shoko Tanaka

|Nov 27, 2024
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Kentaro Hisada

|Nov 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Kentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami

|Nov 09, 2024
Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.

Kaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima

|Feb 26, 2024
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics.

Yuta Kaizuka, Hiroyuki Suzuki, Tadashi Watabe

|Dec 05, 2020
α-Emitting cancer therapy using 211 At-AAMT targeting LAT1.

Kazuko Kaneda-Nakashima, ZiJian Zhang, Yoshiyuki Manabe

Pageof 2

Frequent Collaborators

6 joint publications

Tadashi Watabe

4 joint publications

Kazuko Kaneda-Nakashima

3 joint publications

Koichi Fukase

3 joint publications

Yoshifumi Shirakami